{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:01:10Z","timestamp":1790805670139,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"l'Agence de la Biom\u00e9decine"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jcyt.2017.12.010","type":"journal-article","created":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T17:24:57Z","timestamp":1519925097000},"page":"524-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study"],"prefix":"10.1016","volume":"20","author":[{"given":"Arnaud","family":"Campidelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongsheng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Laroye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Decot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Reppel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"D'aveni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00e8le","family":"Bensoussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2017.12.010_bib0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.bmt.1703873","article-title":"Transplant center characteristics and clinical outcomes after hematopoietic stem cell transplantation: what do we know?","volume":"31","author":"Loberiza","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0015","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1038\/sj.leu.2403105","article-title":"Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen","volume":"17","author":"Mohty","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0020","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2004.05331.x","article-title":"Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation","volume":"128","author":"Feuchtinger","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0025","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.V100.6.2235","article-title":"Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations","volume":"100","author":"Lewin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0030","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.bbmt.2010.03.020","article-title":"Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease","volume":"16","author":"Cantoni","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0035","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/bmt.2008.238","article-title":"Correlations of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation","volume":"42","author":"Wang","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0040","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbmt.2011.12.579","article-title":"Early human herpesvirus type 6 reactivation after allogeneic stem cell transplantation: a large-scale clinical study","volume":"18","author":"Dulery","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0045","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.transproceed.2011.01.028","article-title":"Molecular impact and inducible factors associated with adenovirus infection in hematopoietic stem [corrected] cell transplant patients","volume":"43","author":"Yaghobi","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s15010-016-0872-4","article-title":"Reactivation of polyomavirus in the genitourinary tract is significantly associated with severe GvHD and oral mucositis following allogeneic stem cell transplantation","volume":"44","author":"Peterson","year":"2016","journal-title":"Infection"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0060","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0065","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0070","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/ejh.12848","article-title":"BKV-specific T cells in the treatment of severe refractory haemorrhagic cystitis after HLA-haploidentical haematopoietic cell transplantation","volume":"98","author":"Pello","year":"2017","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0075","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1182\/blood-2014-06-573725","article-title":"Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT","volume":"125","author":"Feucht","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0080","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjh.12251","article-title":"Interferon-gamma capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation","volume":"161","author":"Qasim","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0085","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2009-08-236356","article-title":"Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells","volume":"115","author":"Moosmann","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1200\/JCO.2011.39.8495","article-title":"Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation","volume":"31","author":"Icheva","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0100","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/pbc.24753","article-title":"Adoptive immunotherapy with antigen-specific T cells during extracorporeal membrane oxygenation (ECMO) for adenovirus-related respiratory failure in a child given haploidentical stem cell transplantation","volume":"61","author":"Di Nardo","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0105","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bcmd.2007.07.003","article-title":"Adoptive cellular therapy for cytomegalovirus infection following allogeneic stem cell transplantation using virus-specific T cells","volume":"40","author":"Mackinnon","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0110","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jaci.2016.03.032","article-title":"Specific T cells for the treatment of cytomegalovirus and\/or adenovirus in the context of hematopoietic stem cell transplantation","volume":"138","author":"Creidy","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0115","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13045-017-0469-0","article-title":"Curative or pre-emptive adenovirus-specific T cell transfer from matched unrelated or third party haploidentical donors after HSCT, including UCB transplantations: a successful phase I\/II multicenter clinical trial","volume":"10","author":"Qian","year":"2017","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0120","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/CJI.0b013e3181cc263b","article-title":"Rapid generation of full clinical-grade human antiadenovirus cytotoxic T cells for adoptive immunotherapy","volume":"33","author":"Aissi-Rothe","year":"2010","journal-title":"J Immunother"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0125","first-page":"27","article-title":"Adenovirus-specific t-cell subsets in human peripheral blood and after IFN-gamma immunomagnetic selection","volume":"39","author":"Qian","year":"2016","journal-title":"Journal of immunotherapy (Hagerstown, Md. : 1997)"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0130","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jcyt.2013.07.008","article-title":"Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy","volume":"16","author":"Wang","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0135","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1532-5415.1994.tb06219.x","article-title":"Pharmacokinetics of methylprednisolone in elderly and young healthy males","volume":"42","author":"Tornatore","year":"1994","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0140","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/135245859500100104","article-title":"Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis","volume":"1","author":"Crockard","year":"1995","journal-title":"Mult Scler"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0145","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2249.2002.01725.x","article-title":"Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects","volume":"127","author":"Martinez-Caceres","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2249.2002.01777.x","article-title":"Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs","volume":"128","author":"Strauss","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0155","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/01.TP.0000078623.64968.E5","article-title":"Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine","volume":"76","author":"Zhan","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1365-2567.2012.03594.x","article-title":"Cyclosporin A and tacrolimus reduce T-cell polyfunctionality but not interferon-gamma responses directed at cytomegalovirus","volume":"136","author":"Fuhrmann","year":"2012","journal-title":"Immunology"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0165","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood-2012-11-468660","article-title":"Moving T memory stem cells to the clinic","volume":"121","author":"Gattinoni","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0170","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3324\/haematol.2010.037481","article-title":"Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells","volume":"96","author":"Distler","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0175","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/cyto.a.20643","article-title":"Phenotype and function of human T lymphocyte subsets: consensus and issues","volume":"73","author":"Appay","year":"2008","journal-title":"Cytometry A"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0180","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/nm.4241","article-title":"T memory stem cells in health and disease","volume":"23","author":"Gattinoni","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2017.12.010_bib0185","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2011-08-371971","article-title":"Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation","volume":"119","author":"Doubrovina","year":"2012","journal-title":"Blood"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918300021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324918300021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:34:01Z","timestamp":1761442441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324918300021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1465324918300021"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.12.010","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenovirus-specific T-lymphocyte efficacy in the presence of methylprednisolone: An in vitro study","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}